According to FMS policy, who must sign off to resume normal operations after a chlorine breakthrough?

The requirement for the Medical Director to sign off before resuming normal operations after a chlorine breakthrough stems from their role in overseeing clinical safety and ensuring compliance with health regulations. The Medical Director is responsible for evaluating any risks associated with the incident, including potential harm to patients and staff. Their approval is essential to confirm that all safety protocols have been adhered to and that it is safe to return to standard operations.

In contrast, while the head nurse and other roles play important parts in managing daily operations and immediate response to incidents, they may not have the authority to make final safety decisions regarding the resumption of operations after a significant safety issue, such as a chlorine breakthrough. A quality assurance officer typically focuses on compliance monitoring and audits rather than direct operational safety assessments. The safety officer, although pivotal in emergency management and risk assessments, does not carry the same overarching clinical responsibility as the Medical Director. Therefore, the Medical Director's sign-off is a critical step in ensuring both safety and regulatory compliance before resuming normal activities.